Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local clindamycin before immediate implant placement
IRCT20230607058412N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clindamycin in peri-implantitis (2 arms), sponsored by Islamic Azad University. Primary endpoint: Osseointegration. Started Aug 2023; status: completed.
02
Drugs
clindamycin
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on IRCT20230607058412N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230607058412N1.